Potential therapeutic targets of gastric cancer explored under endogenous network modeling of clinical data

Xile Zhang,Yong-Cong Chen,Mengchao Yao,Ruiqi Xiong,Bingya Liu,Xiaomei Zhu,Ping Ao

DOI: https://doi.org/10.1038/s41598-024-63812-3

IF: 4.6

2024-06-09

Scientific Reports

Abstract:Improvement in the survival rate of gastric cancer, a prevalent global malignancy and the leading cause of cancer-related mortality calls for more avenues in molecular therapy. This work aims to comprehend drug resistance and explore multiple-drug combinations for enhanced therapeutic treatment. An endogenous network modeling clinic data with core gastric cancer molecules, functional modules, and pathways is constructed, which is then transformed into dynamics equations for in-silicon studies. Principal component analysis, hierarchical clustering, and K-means clustering are utilized to map the attractor domains of the stochastic model to the normal and pathological phenotypes identified from the clinical data. The analyses demonstrate gastric cancer as a cluster of stable states emerging within the stochastic dynamics and elucidate the cause of resistance to anti-VEGF monotherapy in cancer treatment as the limitation of the single pathway in preventing cancer progression. The feasibility of multiple objectives of therapy targeting specified molecules and/or pathways is explored. This study verifies the rationality of the platform of endogenous network modeling, which contributes to the development of cross-functional multi-target combinations in clinical trials.

multidisciplinary sciences

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the drug resistance problem in gastric cancer treatment, and it explores multi - drug combination therapies to improve the treatment effect. Specifically, the research constructs an endogenous network model of gastric cancer molecules and cells, and uses clinical data to map the attractor domains of normal and pathological phenotypes, thereby revealing the reasons why gastric cancer is a stable - state cluster emerging in stochastic dynamics, especially explaining the reasons for the limited effectiveness of single - pathway anti - VEGF monotherapy in cancer treatment. The research also explores the feasibility and potential of multiple treatment targets for specific molecules and/or pathways, aiming to guide the development of multi - target combination therapies to improve the efficiency of gastric cancer treatment.

The core of the paper lies in verifying its rationality through an endogenous network modeling platform, which is helpful for the development of cross - functional multi - target combinations in clinical trials. The research not only considers known oncogenic molecules and pathways, such as p53, Myc, Wnt and NF - κB, but also includes molecules particularly related to gastrointestinal development. These molecules are used to study intracellular and extracellular signals and other molecular interactions under normal physiological conditions based on molecular biology and biochemical low - throughput experiments. By dynamically adjusting the relaxation time scale on network nodes, simulating dynamics, and identifying stable attractor domains and their related elements that coordinate the activities of core regulatory molecules, a basis for improving the model is provided. Ultimately, this method may provide valuable insights for the development of multi - target combinations in clinical trials.